Relevance of flow cytometric categorization and end-of-induction measurable residual disease assessment in pediatric and adult T-lymphoblastic leukemia patients.

Autor: Bommannan K; Departments of Oncopathology, Cancer Institute (W.I.A.), Adyar, India., Arumugam JR; Departments of Oncopathology, Cancer Institute (W.I.A.), Adyar, India., Radhakrishnan V; Departments of Medical Oncology, Cancer Institute (W.I.A.), Adyar, India., Kalaiyarasi JP; Departments of Medical Oncology, Cancer Institute (W.I.A.), Adyar, India., Karunakaran P; Departments of Medical Oncology, Cancer Institute (W.I.A.), Adyar, India., Mehra N; Departments of Medical Oncology, Cancer Institute (W.I.A.), Adyar, India., Sagar TG; Departments of Medical Oncology, Cancer Institute (W.I.A.), Adyar, India., Sundersingh S; Departments of Oncopathology, Cancer Institute (W.I.A.), Adyar, India.

Publikováno v: Blood research [Blood Res] 2022 Sep 30; Vol. 57 (3), pp. 175-196. Date of Electronic Publication: 2022 Jul 27.

Cost Effectiveness of Ribociclib and Palbociclib in the Second-Line Treatment of Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer in Post-Menopausal Indian Women.

Autor: Gupta N; Department of Radiation Oncology, Government Medical College and Hospital, Chandigarh, India., Gupta D; Department of Community Medicine and School of Public Health, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India., Dixit J; Department of Community Medicine and School of Public Health, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India., Mehra N; Department of Medical Oncology, Adyar Cancer Institute, Chennai, Tamil Nadu, India., Singh A; Department of Medical Oncology, Christian Medical College, Vellore, Tamil Nadu, India., Krishnamurthy MN; Department of Clinical Pharmacology, Tata Memorial Centre, Mumbai, Maharashtra, India.; Homi Bhabha National Institute, Mumbai, Maharashtra, India., Jyani G; Department of Community Medicine and School of Public Health, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India., Rajsekhar K; Department of Health Research, Ministry of Health and Family Welfare, New Delhi, India., Kalaiyarasi JP; Department of Medical Oncology, Adyar Cancer Institute, Chennai, Tamil Nadu, India., Roy PS; Department of Medical Oncology, Dr. B. Booroah Cancer Institute, Guwahati, Assam, India., Malik PS; Department of Medical Oncology, All India Institute of Medical Sciences (AIIMS), New Delhi, India., Mathew A; Department of Medical Oncology, All India Institute of Medical Sciences (AIIMS), New Delhi, India., Malhotra P; Department of Internal Medicine, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India., Gupta S; Department of Medical Oncology, Tata Memorial Centre, Mumbai, Maharashtra, India.; Homi Bhabha National Institute, Mumbai, Maharashtra, India., Kumar L; Department of Medical Oncology, All India Institute of Medical Sciences (AIIMS), New Delhi, India., Kataki A; Department of Gynaecologic Oncology, Dr. B. Booroah Cancer Institute, Guwahati, Assam, India., Prinja S; Department of Community Medicine and School of Public Health, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India. shankarprinja@gmail.com.

Publikováno v: Applied health economics and health policy [Appl Health Econ Health Policy] 2022 Jul; Vol. 20 (4), pp. 609-621. Date of Electronic Publication: 2022 May 10.

Precursor B-lineage acute lymphoblastic leukemia patients with aberrant natural killer cell and T cell - lineage antigen expression: experience from a tertiary cancer care center.

Autor: Bommannan K; Cancer Institute (W.I.A.), Adyar, Chennai, India. Electronic address: bkkb87@gmail.com., Arumugam JR; Cancer Institute (W.I.A.), Adyar, Chennai, India., Radhakrishnan V; Cancer Institute (W.I.A.), Adyar, Chennai, India., Kalaiyarasi JP; Cancer Institute (W.I.A.), Adyar, Chennai, India., Mehra N; Cancer Institute (W.I.A.), Adyar, Chennai, India., Sagar TG; Cancer Institute (W.I.A.), Adyar, Chennai, India., Sundersingh S; Cancer Institute (W.I.A.), Adyar, Chennai, India.

Publikováno v: Hematology, transfusion and cell therapy [Hematol Transfus Cell Ther] 2022 Apr-Jun; Vol. 44 (2), pp. 143-150. Date of Electronic Publication: 2020 Oct 07.

Therapeutic Outcomes in High-Grade B-Cell Lymphoma, NOS: Retrospective Analysis.

Autor: Karunakaran P; Department of Medical Oncology, Cancer Institute (WIA), Chennai, India., Selvarajan G; Department of Medical Oncology, Cancer Institute (WIA), Chennai, India., Kalaiyarasi JP; Department of Medical Oncology, Cancer Institute (WIA), Chennai, India., Mehra N; Department of Medical Oncology, Cancer Institute (WIA), Chennai, India., Sundersingh S; Department of Onco-Pathology, Cancer Institute (WIA), Chennai, India., Dhanushkodi M; Department of Medical Oncology, Cancer Institute (WIA), Chennai, India., Kesana S; Department of Medical Oncology, Cancer Institute (WIA), Chennai, India., Kannan K; Department of Medical Oncology, Cancer Institute (WIA), Chennai, India., Ganesan TS; Department of Medical Oncology, Cancer Institute (WIA), Chennai, India., Radhakrishnan V; Department of Medical Oncology, Cancer Institute (WIA), Chennai, India., Sagar TG; Department of Medical Oncology, Cancer Institute (WIA), Chennai, India.

Publikováno v: South Asian journal of cancer [South Asian J Cancer] 2022 Feb 02; Vol. 11 (1), pp. 68-72. Date of Electronic Publication: 2022 Feb 02 (Print Publication: 2022).

Outcomes in adolescent and young adult acute lymphoblastic leukaemia: a report from the Indian Acute Leukaemia Research Database (INwARD) of the Hematology Cancer Consortium (HCC).

Autor: Ganesan P; Department of Medical Oncology, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Puducherry, India., Jain H; Department of Medical Oncology, Adult Hematolymphoid Disease Management Group, Tata Memorial Centre, Mumbai, India., Bagal B; Department of Medical Oncology, Adult Hematolymphoid Disease Management Group, Tata Memorial Centre, Mumbai, India., Subramanian PG; Hematopathology Laboratory, Tata Memorial Centre, Mumbai, India., George B; Department of Haematology, Christian Medical College, Vellore, India., Korula A; Department of Haematology, Christian Medical College, Vellore, India., Mehra N; Department of Medical Oncology, Cancer Institute (WIA), Chennai, India., Kalaiyarasi JP; Department of Medical Oncology, Cancer Institute (WIA), Chennai, India., Bhurani D; Department of Hemato-Oncology, Rajiv Gandhi Cancer Institute and Research Centre, New Delhi, India., Agrawal N; Department of Hemato-Oncology, Rajiv Gandhi Cancer Institute and Research Centre, New Delhi, India., Ahmed R; Department of Hemato-Oncology, Rajiv Gandhi Cancer Institute and Research Centre, New Delhi, India., Kayal S; Department of Medical Oncology, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Puducherry, India., Bhattacharyya J; Department of Clinical Hematology, Gauhati Medical College and Hospital, Gauhati, India., Yanamandra U; Department of Hematology, Army Hospital (Research and Referral), New Delhi, India., Kumar S; Department of Hematology, Army Hospital (Research and Referral), New Delhi, India., Philip CC; Department of Clinical Haematology, Christian Medical College and Hospital, Ludhiana, India., John MJ; Department of Clinical Haematology, Christian Medical College and Hospital, Ludhiana, India., Nadaraj A; Department of Biostatistics, Christian Medical College, Vellore, India., Karunamurthy O; Department of Biostatistics, Christian Medical College, Vellore, India., Lakshmanan J; Department of Biostatistics, Christian Medical College, Vellore, India., Mathews V; Department of Haematology, Christian Medical College, Vellore, India., Sengar M; Department of Medical Oncology, Adult Hematolymphoid Disease Management Group, Tata Memorial Centre, Mumbai, India.

Publikováno v: British journal of haematology [Br J Haematol] 2021 Apr; Vol. 193 (1), pp. e1-e4. Date of Electronic Publication: 2021 Mar 03.